Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-blind studies

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dkh207 ◽

2004 ◽

Vol 53 (suppl_2) ◽

pp. ii59-ii66 ◽

Author(s):

G. Ortiz-Ruiz

Keyword(s):

Community Acquired Pneumonia ◽

Double Blind ◽

Combined Analysis

Download Full-text

Faculty Opinions recommendation of Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.11256960.14276054 ◽

2011 ◽

Author(s):

Paul Pham ◽

Neal Vasist

Keyword(s):

Hospital Stay ◽

Controlled Trial ◽

Length Of Hospital Stay ◽

Community Acquired Pneumonia ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725300024.793514641 ◽

2016 ◽

Author(s):

Sebastian R Ott

Keyword(s):

Inflammatory Cytokines ◽

Controlled Trial ◽

Community Acquired Pneumonia ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725322133.793504871 ◽

2015 ◽

Author(s):

Charles Feldman ◽

Erica Shaddock

Keyword(s):

Controlled Trial ◽

Community Acquired Pneumonia ◽

Double Blind ◽

Prednisone Therapy

Download Full-text

A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged ≥65 years with community-acquired pneumonia

Clinical Therapeutics ◽

10.1016/s0149-2918(05)80214-0 ◽

2005 ◽

Vol 27 (8) ◽

pp. 1251-1259 ◽

Author(s):

Andrew F. Shorr ◽

Neringa Zadeikis ◽

Jim X. Xiang ◽

Alan M. Tennenberg ◽

E. Wes Ely

Keyword(s):

Community Acquired Pneumonia ◽

Double Blind ◽

Retrospective Comparison

Download Full-text

Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/48.5.735 ◽

2001 ◽

Vol 48 (5) ◽

pp. 735-735 ◽

Author(s):

Margaret R. Hammerschlag

Keyword(s):

Community Acquired Pneumonia ◽

Efficacy And Safety ◽

Double Blind ◽

Blind Comparison

Download Full-text

Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial

10.1016/s0140-6736(11)60607-7 ◽

2011 ◽

Vol 377 (9782) ◽

pp. 2023-2030 ◽

Author(s):

Sabine CA Meijvis ◽

Hans Hardeman ◽

Hilde HF Remmelts ◽

Rik Heijligenberg ◽

Ger T Rijkers ◽

...

Keyword(s):

Hospital Stay ◽

Controlled Trial ◽

Length Of Hospital Stay ◽

Community Acquired Pneumonia ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial

10.1016/s0140-6736(14)62447-8 ◽

2015 ◽

Vol 385 (9977) ◽

pp. 1511-1518 ◽

Author(s):

Claudine Angela Blum ◽

Nicole Nigro ◽

Matthias Briel ◽

Philipp Schuetz ◽

Elke Ullmer ◽

...

Keyword(s):

Controlled Trial ◽

Community Acquired Pneumonia ◽

Double Blind ◽

Prednisone Therapy

Download Full-text

Hospital antibiotic course length for community-acquired pneumonia

Drug and Therapeutics Bulletin ◽

10.1136/dtb.2021.000057 ◽

2021 ◽

pp. dtb-2021-000057

Keyword(s):

Critical Care ◽

Community Acquired Pneumonia ◽

Double Blind ◽

AbstractOverview of: Dinh A, Ropers J, Duran C, et al. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet 2021;397:1195–203.

Download Full-text

A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia

Clinical Therapeutics ◽

10.1016/s0149-2918(02)85148-7 ◽

2002 ◽

Vol 24 (5) ◽

pp. 736-751 ◽

Author(s):

Mark H. Gotfried ◽

Dan Dattani ◽

Ernie Riffer ◽

Karen J. Devcich ◽

Todd A. Busman ◽

...

Keyword(s):

Multicenter Study ◽

Extended Release ◽

Community Acquired Pneumonia ◽

Download Full-text

Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial

Journal of Microbiology Immunology and Infection ◽

10.1016/j.jmii.2017.07.011 ◽

2019 ◽

Vol 52 (1) ◽

pp. 35-44 ◽

Author(s):

Jinyi Yuan ◽

Biwen Mo ◽

Zhuang Ma ◽

Yuan Lv ◽

Shih-Lung Cheng ◽

...

Keyword(s):

Community Acquired Pneumonia ◽

Phase 3 ◽

Double Blind ◽

Safety And Efficacy

Download Full-text